Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
about
Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatmentHistone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune TherapyAlternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem CellsTegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme.Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cellsA novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.Hepatocyte growth factor protects human mesangial cells against apoptosis induced by lead damage.Melanoma never says die.Cell cycle-tailored targeting of metastatic melanoma: Challenges and opportunities.Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin.HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma.JNK-ERK signalling in melanoma: rewired or entangled?17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells.Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860
Q26776032-B52CFE6F-9425-4E6A-A3D2-97756892F812Q26783032-5953FA16-7144-4E48-9418-E5A605C8D4B8Q28084243-9464D67E-9E97-45F9-8B93-F0B5D5F971F7Q35278136-6337FD85-0FA5-42B1-B318-9A7D465EE6B7Q36974284-F666CF41-3255-43DD-BBB2-8163D4A221B2Q37559800-79DB0AB8-8A3C-44CA-B9CD-35C42A6F788FQ37708989-DAC15496-C4CC-414B-8DA2-408D28B16EBFQ38830266-43A8CCF2-BA0B-47E7-AA43-A27151CCF236Q38944587-27115BF4-3350-4616-AB2B-1FA3254671E0Q38947009-911DE7C5-D44D-49B2-B7EA-A2E6E145A6EDQ38963112-25C82158-DDC4-464D-94B5-4FBD99647B21Q39010041-FE690049-BCC5-4C1F-9E2D-1FF24894E72BQ39191984-5A08BCED-8B72-44EB-B69D-85599CD59A9BQ41470758-2132214B-8887-4AF2-9F16-F87B9953EFC0Q41472744-1DF0C403-592D-43CE-B722-02B4532D2719Q47325071-381575C1-669D-4EA0-84F3-EB59CAB2F1ECQ49265106-2DC7E7B5-6CA7-407A-8FFD-BD6287790310Q51248678-EC18D537-1FDE-48EE-B78A-539032BB5F36Q53361782-DBF88587-A06B-43F1-9382-233325161055Q54978342-D864C678-5E8F-4EE2-9132-43EFB05999FFQ58763373-A8465BFB-BAFE-4170-9552-21031ADF819E
P2860
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@en
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@nl
type
label
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@en
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@nl
prefLabel
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@en
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@nl
P2860
P356
P1476
Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.
@en
P2093
David S Hill
John D Allen
P2860
P304
P356
10.1111/PCMR.12242
P577
2014-04-09T00:00:00Z